Inhibition of mitochondrial complex II in neuronal cells triggers unique pathways culminating in autophagy with implications for neurodegeneration
Abstract Mitochondrial dysfunction and neurodegeneration underlie movement disorders such as Parkinson’s disease, Huntington’s disease and Manganism among others. As a corollary, inhibition of mitochondrial complex I (CI) and complex II (CII) by toxins 1-methyl-4-phenylpyridinium (MPP+) and 3-nitrop...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-020-79339-2 |
id |
doaj-509a1a41dea843ee9b5ffad39e1ca7da |
---|---|
record_format |
Article |
spelling |
doaj-509a1a41dea843ee9b5ffad39e1ca7da2021-01-17T12:34:43ZengNature Publishing GroupScientific Reports2045-23222021-01-0111112310.1038/s41598-020-79339-2Inhibition of mitochondrial complex II in neuronal cells triggers unique pathways culminating in autophagy with implications for neurodegenerationSathyanarayanan Ranganayaki0Neema Jamshidi1Mohamad Aiyaz2Santhosh-Kumar Rashmi3Narayanappa Gayathri4Pulleri Kandi Harsha5Balasundaram Padmanabhan6Muchukunte Mukunda Srinivas Bharath7Department of Neurochemistry, National Institute of Mental Health and Neurosciences (NIMHANS)Department of Radiological Sciences, Ronald Reagan UCLA Medical CenterGenotypic Technology Pvt. Ltd.Department of Neuropathology, NIMHANSDepartment of Neuropathology, NIMHANSDepartment of Neurovirology, NIMHANSDepartment of Biophysics, NIMHANSDepartment of Clinical Psychopharmacology and Neurotoxicology, National Institute of Mental Health and Neurosciences (NIMHANS)Abstract Mitochondrial dysfunction and neurodegeneration underlie movement disorders such as Parkinson’s disease, Huntington’s disease and Manganism among others. As a corollary, inhibition of mitochondrial complex I (CI) and complex II (CII) by toxins 1-methyl-4-phenylpyridinium (MPP+) and 3-nitropropionic acid (3-NPA) respectively, induced degenerative changes noted in such neurodegenerative diseases. We aimed to unravel the down-stream pathways associated with CII inhibition and compared with CI inhibition and the Manganese (Mn) neurotoxicity. Genome-wide transcriptomics of N27 neuronal cells exposed to 3-NPA, compared with MPP+ and Mn revealed varied transcriptomic profile. Along with mitochondrial and synaptic pathways, Autophagy was the predominant pathway differentially regulated in the 3-NPA model with implications for neuronal survival. This pathway was unique to 3-NPA, as substantiated by in silico modelling of the three toxins. Morphological and biochemical validation of autophagy markers in the cell model of 3-NPA revealed incomplete autophagy mediated by mechanistic Target of Rapamycin Complex 2 (mTORC2) pathway. Interestingly, Brain Derived Neurotrophic Factor (BDNF), which was elevated in the 3-NPA model could confer neuroprotection against 3-NPA. We propose that, different downstream events are activated upon neurotoxin-dependent CII inhibition compared to other neurotoxins, with implications for movement disorders and regulation of autophagy could potentially offer neuroprotection.https://doi.org/10.1038/s41598-020-79339-2 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sathyanarayanan Ranganayaki Neema Jamshidi Mohamad Aiyaz Santhosh-Kumar Rashmi Narayanappa Gayathri Pulleri Kandi Harsha Balasundaram Padmanabhan Muchukunte Mukunda Srinivas Bharath |
spellingShingle |
Sathyanarayanan Ranganayaki Neema Jamshidi Mohamad Aiyaz Santhosh-Kumar Rashmi Narayanappa Gayathri Pulleri Kandi Harsha Balasundaram Padmanabhan Muchukunte Mukunda Srinivas Bharath Inhibition of mitochondrial complex II in neuronal cells triggers unique pathways culminating in autophagy with implications for neurodegeneration Scientific Reports |
author_facet |
Sathyanarayanan Ranganayaki Neema Jamshidi Mohamad Aiyaz Santhosh-Kumar Rashmi Narayanappa Gayathri Pulleri Kandi Harsha Balasundaram Padmanabhan Muchukunte Mukunda Srinivas Bharath |
author_sort |
Sathyanarayanan Ranganayaki |
title |
Inhibition of mitochondrial complex II in neuronal cells triggers unique pathways culminating in autophagy with implications for neurodegeneration |
title_short |
Inhibition of mitochondrial complex II in neuronal cells triggers unique pathways culminating in autophagy with implications for neurodegeneration |
title_full |
Inhibition of mitochondrial complex II in neuronal cells triggers unique pathways culminating in autophagy with implications for neurodegeneration |
title_fullStr |
Inhibition of mitochondrial complex II in neuronal cells triggers unique pathways culminating in autophagy with implications for neurodegeneration |
title_full_unstemmed |
Inhibition of mitochondrial complex II in neuronal cells triggers unique pathways culminating in autophagy with implications for neurodegeneration |
title_sort |
inhibition of mitochondrial complex ii in neuronal cells triggers unique pathways culminating in autophagy with implications for neurodegeneration |
publisher |
Nature Publishing Group |
series |
Scientific Reports |
issn |
2045-2322 |
publishDate |
2021-01-01 |
description |
Abstract Mitochondrial dysfunction and neurodegeneration underlie movement disorders such as Parkinson’s disease, Huntington’s disease and Manganism among others. As a corollary, inhibition of mitochondrial complex I (CI) and complex II (CII) by toxins 1-methyl-4-phenylpyridinium (MPP+) and 3-nitropropionic acid (3-NPA) respectively, induced degenerative changes noted in such neurodegenerative diseases. We aimed to unravel the down-stream pathways associated with CII inhibition and compared with CI inhibition and the Manganese (Mn) neurotoxicity. Genome-wide transcriptomics of N27 neuronal cells exposed to 3-NPA, compared with MPP+ and Mn revealed varied transcriptomic profile. Along with mitochondrial and synaptic pathways, Autophagy was the predominant pathway differentially regulated in the 3-NPA model with implications for neuronal survival. This pathway was unique to 3-NPA, as substantiated by in silico modelling of the three toxins. Morphological and biochemical validation of autophagy markers in the cell model of 3-NPA revealed incomplete autophagy mediated by mechanistic Target of Rapamycin Complex 2 (mTORC2) pathway. Interestingly, Brain Derived Neurotrophic Factor (BDNF), which was elevated in the 3-NPA model could confer neuroprotection against 3-NPA. We propose that, different downstream events are activated upon neurotoxin-dependent CII inhibition compared to other neurotoxins, with implications for movement disorders and regulation of autophagy could potentially offer neuroprotection. |
url |
https://doi.org/10.1038/s41598-020-79339-2 |
work_keys_str_mv |
AT sathyanarayananranganayaki inhibitionofmitochondrialcomplexiiinneuronalcellstriggersuniquepathwaysculminatinginautophagywithimplicationsforneurodegeneration AT neemajamshidi inhibitionofmitochondrialcomplexiiinneuronalcellstriggersuniquepathwaysculminatinginautophagywithimplicationsforneurodegeneration AT mohamadaiyaz inhibitionofmitochondrialcomplexiiinneuronalcellstriggersuniquepathwaysculminatinginautophagywithimplicationsforneurodegeneration AT santhoshkumarrashmi inhibitionofmitochondrialcomplexiiinneuronalcellstriggersuniquepathwaysculminatinginautophagywithimplicationsforneurodegeneration AT narayanappagayathri inhibitionofmitochondrialcomplexiiinneuronalcellstriggersuniquepathwaysculminatinginautophagywithimplicationsforneurodegeneration AT pullerikandiharsha inhibitionofmitochondrialcomplexiiinneuronalcellstriggersuniquepathwaysculminatinginautophagywithimplicationsforneurodegeneration AT balasundarampadmanabhan inhibitionofmitochondrialcomplexiiinneuronalcellstriggersuniquepathwaysculminatinginautophagywithimplicationsforneurodegeneration AT muchukuntemukundasrinivasbharath inhibitionofmitochondrialcomplexiiinneuronalcellstriggersuniquepathwaysculminatinginautophagywithimplicationsforneurodegeneration |
_version_ |
1724334610667536384 |